Immunoglobulin enhancer HS1,2 polymorphism: A new powerful anthropogenetic marker

dc.contributor.authorGiambra, Vincenzo
dc.contributor.authorMartinez, Labarga Cristina
dc.contributor.authorGiufre, Maria
dc.contributor.authorModiano, D.
dc.contributor.authorSimpore, Jacques
dc.contributor.authorGisladottir, B. K.
dc.contributor.authorFrancavilla, R.
dc.contributor.authorZhelezova, Galina
dc.contributor.authorCrawford, M.
dc.contributor.authorBiondi, Gianfranco
dc.contributor.authorRickards, Olga
dc.contributor.authorFrezza, Damon
dc.contributor.buuauthorKılıç, Sara Şebnem
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Pediatri Anabilim Dalı.tr_TR
dc.contributor.researcheridAAH-1658-2021tr_TR
dc.contributor.scopusid34975059200tr_TR
dc.date.accessioned2021-10-19T11:18:48Z
dc.date.available2021-10-19T11:18:48Z
dc.date.issued2006
dc.description.abstractThe human HS1,2 enhancer of the immunoglobulin (Ig) heavy chain 3' enhancer complex plays a central role in the regulation of Ig maturation and production. Four common alleles HS1,2-A*1, *2, *3, *4 are directly implicated with the transcription level and at least one of them, HS1, 2-A*2, seems to be related to immune disorders, such as coeliac disease, herpetiform dermatitis and Berger syndrome. Given their clinical significance it is of interest to know the distribution of HS1,2-A variants in populations from different continents, as well as to determine whether the polymorphism is associated to specific evolutionary factors. In this paper we report the distribution of the HS1,2-A polymorphism in 1098 individuals from various African, Asian and European populations. HS1,2-A*3 and HS1,2-A*4 alleles are at their highest frequencies among Africans, and HS1,2-A*2 is significantly lower in Africans in comparison with both Europeans and, to a lesser extent, Asians. Analysis of molecular variance of the allele frequencies indicates that the HS1,2-A polymorphism can be considered as a reliable anthropogenetic marker.en_US
dc.identifier.citationGiambra, V. vd. (2006). ''Immunoglobulin enhancer HS1,2 polymorphism: A new powerful anthropogenetic marker''. Annals of Human Genetics, 70(6), 946-950.en_US
dc.identifier.endpage950tr_TR
dc.identifier.issn0003-4800
dc.identifier.issue6tr_TR
dc.identifier.pubmed17044868tr_TR
dc.identifier.scopus2-s2.0-33749556410tr_TR
dc.identifier.startpage946tr_TR
dc.identifier.urihttps://doi.org/10.1111/j.1469-1809.2006.00273.x
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/10.1111/j.1469-1809.2006.00273.x
dc.identifier.urihttp://hdl.handle.net/11452/22410
dc.identifier.volume70tr_TR
dc.identifier.wos000241191400025tr_TR
dc.indexed.pubmedPubmeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.collaborationYurt dışıtr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.journalAnnals of Human Geneticsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGenetics & heredityen_US
dc.subjectRegulatory regionen_US
dc.subjectImmunoglobulinesen_US
dc.subjectImmune-pathologiesen_US
dc.subjectHuman populationsen_US
dc.subjectHS1,2 Ig enhanceren_US
dc.subjectAllelic frequenciesen_US
dc.subjectDiseasesen_US
dc.subjectEvolutionen_US
dc.subjectPromotersen_US
dc.subjectPopulationen_US
dc.subjectIga nephropathyen_US
dc.subject.emtreeUnclassified drugen_US
dc.subject.emtreeImmunoglobulin heavy chain 3' enhancer complex 1en_US
dc.subject.emtreeImmunoglobulin enhancer binding proteinen_US
dc.subject.emtreeTranscription regulationen_US
dc.subject.emtreeReliabilityen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreePopulation geneticsen_US
dc.subject.emtreePolymerase chain reactionen_US
dc.subject.emtreeNucleotide sequenceen_US
dc.subject.emtreeMolecular geneticsen_US
dc.subject.emtreeImmunopathologyen_US
dc.subject.emtreeImmunoglobulin productionen_US
dc.subject.emtreeImmunoglobulin A nephropathyen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeGenetic variabilityen_US
dc.subject.emtreeGenetic polymorphismen_US
dc.subject.emtreeGenetic markeren_US
dc.subject.emtreeGene frequencyen_US
dc.subject.emtreeEuropeen_US
dc.subject.emtreeDermatitis herpetiformisen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeCeliac diseaseen_US
dc.subject.emtreeAsianen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeAlleleen_US
dc.subject.emtreeAfricaen_US
dc.subject.meshPolymorphism, geneticen_US
dc.subject.meshModels, geneticen_US
dc.subject.meshAfrican continental ancestry groupen_US
dc.subject.meshHumansen_US
dc.subject.meshGenetics, populationen_US
dc.subject.meshGenetic markersen_US
dc.subject.meshGenes, immunoglobulin heavy chainen_US
dc.subject.meshGene frequencyen_US
dc.subject.meshEuropean continental ancestry groupen_US
dc.subject.meshEnhancer elements, geneticen_US
dc.subject.meshEnhancer elements (genetics)en_US
dc.subject.meshAsian continental ancestry groupen_US
dc.subject.scopusImmunoglobulin Heavy Chains; Regulatory Sequences; AICDA (Activation-induced Cytidine Deaminase)en_US
dc.subject.wosGenetics & heredityen_US
dc.titleImmunoglobulin enhancer HS1,2 polymorphism: A new powerful anthropogenetic markeren_US
dc.typeArticle
dc.wos.quartileQ2en_US

Files

License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: